Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04497584 · ClinicalTrials.gov registry record · Phase 2
Phase 2 Trial of Afatinib Plus Prednisone for Advanced Squamous NSCLC
A Phase 2 study of Advanced Squamous Non Small Cell Lung Cancer, sponsored by University of Texas Southwestern Medical Center.
- Active
- Registry status
- Phase 2
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT04497584: Active Phase 2 study of Advanced Squamous Non Small Cell Lung Cancer, sponsored by University of Texas Southwestern Medical Center.
NCT04497584 is a Phase 2 study of Advanced Squamous Non Small Cell Lung Cancer that is active but no longer recruiting, run by University of Texas Southwestern Medical Center. The registered enrollment target is 12 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04497584, a Phase 2 study of Advanced Squamous Non Small Cell Lung Cancer, is active but no longer recruiting, sponsored by University of Texas Southwestern Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine the efficacy of combined afatinib and prednisone in previously treated advanced squamous NSCLC
Primary Outcome
Measure progression-free survival rate.
Conditions Studied
Interventions
- DRUG Afatinib + Prednisone
Study Locations (1)
Texas
- UT Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2021-08-04 |
| Est. Completion | 2027-09-01 |
| Phase | Phase 2 |
What the registry record for NCT04497584 still lists
NCT04497584 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Advanced Squamous Non Small Cell Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Afatinib + Prednisone is the first listed.
NCT04497584 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04497584 about?
NCT04497584 is a clinical study titled "Phase 2 Trial of Afatinib Plus Prednisone for Advanced Squamous NSCLC". To determine the efficacy of combined afatinib and prednisone in previously treated advanced squamous NSCLC
What is the current status of trial NCT04497584?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 12 participants. The study started on 2021-08-04. Estimated completion is 2027-09-01.
What conditions does trial NCT04497584 study?
This clinical trial studies the following conditions: Advanced Squamous Non Small Cell Lung Cancer.
What interventions are being tested in trial NCT04497584?
The interventions under investigation include: Afatinib + Prednisone (DRUG).
Who is sponsoring clinical trial NCT04497584?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04497584 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04497584's enrollment target sits among peer trials
12 1948th of 2000 higher than 34 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI